Loading market dashboard
Takeda Pharmaceutical Company Limited
TAKHealthcareNYSEJP
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Takeda Pharmaceutical Company Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Mar 2031 | $5.15T | $4.90T - $5.39T | $1.51T | $118.54 | 3 |
| Mar 2030 | $5.14T | $4.89T - $5.39T | $1.50T | $131.83 | 4 |
| Mar 2029 | $4.84T | $4.61T - $5.07T | $1.42T | $122.56 | 4 |
| Mar 2028 | $4.72T | $4.57T - $4.87T | $1.38T | $99.503 | 8 |
| Mar 2027 | $4.65T | $4.63T - $4.67T | $1.36T | $70.054 | 8 |
| Mar 2026 | $4.62T | $4.40T - $4.85T | $1.35T | $71.796 | 8 |
| Mar 2025 | $4.70T | $4.69T - $4.70T | $1.37T | $43.55 | 9 |
| Mar 2024 | $4.11T | $4.01T - $4.22T | $1.23T | $44.617 | 3 |
| Mar 2023 | $3.98T | $3.89T - $4.06T | $1.19T | $100.23 | 1 |
| Mar 2022 | $3.49T | $3.41T - $3.56T | $1.04T | $75.365 | 1 |
| Mar 2021 | $3.27T | $3.20T - $3.34T | $976.20B | $85.988 | 1 |
| Mar 2020 | $3.29T | $3.21T - $3.36T | $979.62B | -$48.10 | 1 |